HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.700

+0.1454.08%

Volume:735.40K

Turnover:2.74M

Market Cap:1.59B

PE:-6.98

High:3.795

Open:3.600

Low:3.600

Close:3.555

52wk High:16.800

52wk Low:2.800

Shares:429.00M

HK Float Shares:418.00M

Volume Ratio:1.40

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.530

ROE:-29.87%

ROA:-13.80%

PB:1.72

PE(LYR):-6.98

PS:8.82

Loading ...

Overview Company News Filings

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million

ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed

Bulletin Express

IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed

ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003

ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus

Bulletin Express

ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial

ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial

THOMSON REUTERS

ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation

Bulletin Express

ImmuneOnco Biopharmaceuticals Schedules Board Meeting to Review Interim Results

Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge

Hong Kong Stock Movers: IMMUNEONCO-B (01541) Surges Over 14% as Subsidiary Secures First External Commercial Capital to Accelerate Non-Oncology Pipeline

IMMUNEONCO-B shares surge nearly 10% in afternoon trading after subsidiary raises 50 million yuan

IMMUNEONCO-B's Unit Receives 50 Million Yuan Capital Injection

ImmuneOnco Affiliate ImmuneCare Attracts RMB 50 Million in Capital Increase for 15.83% Stake

ImmuneOnco injects RMB50.00 million into ImmuneCare; retains 68.34% stake after capital boost

Bulletin Express

ImmuneOnco trims outstanding H-shares by 0.58 million in July; treasury stock rises to 2.02 million

Bulletin Express

IMMUNEONCO-B Implements ESOP-Driven Capital Injection into Non-Oncology Subsidiary, Adjusts Shareholding Structure

Bulletin Express

ImmuneOnco Clarifies Subsidiary Capital Increase as Employee Incentive Scheme Via ESOP Platform

ImmuneOnco Completes HKD 0.19 Million H-Share Buyback, Issued Share Count Trimmed to 418.46 Million

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/stock/01541/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":3.7,"timestamp":1787731681429,"preClose":3.555,"halted":0,"volume":735400,"delay":0,"changeRate":0.04078762306610408,"floatShares":418000000,"shares":429000000,"eps":-0.53,"marketStatus":"Not Yet Opened","change":0.145,"latestTime":"08-26 16:08:01","open":3.6,"high":3.795,"low":3.6,"amount":2738025,"amplitude":0.054852,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.589757,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":3.555,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"volumeRatio":1.3996539119318445,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":418000000,"roa":"-13.80%","roe":"-29.87%","lyrEps":-0.53,"volumeRatio":1.3996539119318445,"shares":429000000,"dividePrice":0,"high":3.795,"amplitude":0.054852,"preClose":3.555,"low":3.6,"week52Low":2.8,"pbRate":"1.72","psRate":"8.82","week52High":16.8,"institutionHeld":0,"latestPrice":3.7,"eps":-0.53,"divideRate":0,"volume":735400,"delay":0,"ttmEps":-0.589757,"open":3.6,"prevYearClose":5.83,"fiveDayClose":3.31,"twentyDayClose":3.1,"sixtyDayClose":2.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-08-25","current":-6.27377,"percent":0.770178,"low":-30.003263,"twenty":-16.420084,"median":-9.443501,"eighty":-5.864459,"high":-2.993766,"avg":-11.902791,"sd":7.008793,"marketCap":1534009855},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-06","current":-5.480977,"twenty":-18.467104,"median":-12.547098,"eighty":-6.250095,"marketCap":1868428319},{"date":"2026-02-13","current":-5.764322,"twenty":-18.451463,"median":-12.334661,"eighty":-6.129552,"marketCap":1976305243},{"date":"2026-02-20","current":-5.709616,"twenty":-18.447248,"median":-12.324382,"eighty":-6.122036,"marketCap":1954729858},{"date":"2026-02-27","current":-5.173921,"twenty":-18.36049,"median":-12.246119,"eighty":-6.086335,"marketCap":1790756934},{"date":"2026-03-06","current":-5.567891,"twenty":-18.158064,"median":-12.065853,"eighty":-6.054191,"marketCap":1911579088},{"date":"2026-03-13","current":-6.117869,"twenty":-18.015354,"median":-11.997781,"eighty":-6.054191,"marketCap":2110072628},{"date":"2026-03-20","current":-5.927628,"twenty":-17.916043,"median":-11.941476,"eighty":-6.046952,"marketCap":2036716320},{"date":"2026-03-27","current":-7.775976,"twenty":-17.807771,"median":-11.897801,"eighty":-5.998519,"marketCap":1924524319},{"date":"2026-04-02","current":-8.241979,"twenty":-17.7975,"median":-11.83436,"eighty":-6.013995,"marketCap":2049661551},{"date":"2026-04-10","current":-8.161679,"twenty":-17.786583,"median":-11.824288,"eighty":-6.015601,"marketCap":2045346474},{"date":"2026-04-17","current":-10.223634,"twenty":-17.753464,"median":-11.822864,"eighty":-6.03821,"marketCap":2563155708},{"date":"2026-04-24","current":-8.708527,"twenty":-17.740948,"median":-11.788146,"eighty":-6.050175,"marketCap":2183428936},{"date":"2026-04-30","current":-8.01805,"twenty":-17.720998,"median":-11.771721,"eighty":-6.055393,"marketCap":2010825858},{"date":"2026-05-08","current":-7.201573,"twenty":-17.693999,"median":-11.728007,"eighty":-6.067488,"marketCap":1812332319},{"date":"2026-05-15","current":-6.019771,"twenty":-17.681444,"median":-11.664585,"eighty":-6.067488,"marketCap":1518907086},{"date":"2026-05-22","current":-5.845011,"twenty":-17.559701,"median":-11.603261,"eighty":-6.055393,"marketCap":1471441239},{"date":"2026-05-29","current":-5.00485,"twenty":-17.377503,"median":-11.514742,"eighty":-6.021369,"marketCap":1264317546},{"date":"2026-06-05","current":-5.406956,"twenty":-17.219881,"median":-11.323354,"eighty":-5.987951,"marketCap":1367879393},{"date":"2026-06-12","current":-6.161616,"twenty":-17.185737,"median":-11.281569,"eighty":-5.974648,"marketCap":1557742778},{"date":"2026-06-18","current":-6.148633,"twenty":-17.12503,"median":-11.173523,"eighty":-5.983773,"marketCap":1557742778},{"date":"2026-06-26","current":-6.245478,"twenty":-17.024379,"median":-10.700224,"eighty":-5.984776,"marketCap":1575003086},{"date":"2026-07-03","current":-6.68536,"twenty":-16.923645,"median":-10.487176,"eighty":-5.987546,"marketCap":1687195087},{"date":"2026-07-10","current":-5.923214,"twenty":-16.909148,"median":-10.312858,"eighty":-5.984083,"marketCap":1493016624},{"date":"2026-07-17","current":-5.902209,"twenty":-16.682476,"median":-10.158539,"eighty":-5.968616,"marketCap":1493016624},{"date":"2026-07-24","current":-5.542738,"twenty":-16.623143,"median":-9.958283,"eighty":-5.926348,"marketCap":1402400008},{"date":"2026-07-31","current":-5.106671,"twenty":-16.606785,"median":-9.895629,"eighty":-5.905868,"marketCap":1294523085},{"date":"2026-08-07","current":-5.351615,"twenty":-16.539438,"median":-9.757608,"eighty":-5.872434,"marketCap":1359249239},{"date":"2026-08-14","current":-6.61743,"twenty":-16.502556,"median":-9.567144,"eighty":-5.872434,"marketCap":1682880010},{"date":"2026-08-21","current":-5.73939,"twenty":-16.475236,"median":-9.478992,"eighty":-5.870008,"marketCap":1462811086},{"date":"2026-08-25","current":-6.017743,"twenty":-16.420084,"median":-9.443501,"eighty":-5.864459,"marketCap":1534009855}],"updateTime":1787753651753},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","MDTX","BK1161","01541","BMED","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708712","title":"ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708712","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:41","pubTimestamp":1787751717,"startTime":"0","endTime":"0","summary":"ImmuneOnco FY26 interim revenue falls 33.2% to RMB 25.4 million; R&D expenses drop 7.9% to RMB 154.8 millionImmuneOnco posted revenue of RMB 25.4 million for the six months ended June 30, 2026, down 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2N6WK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118698746","title":"ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1118698746","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118698746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:47","pubTimestamp":1787654850,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has reported two key advances for its independently developed activin receptor type IIA-Fc fusion protein, IMC-003/IMM72. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192850803","title":"IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1192850803","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192850803?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:44","pubTimestamp":1787654653,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced two significant clinical milestones for IMC-003/IMM72, a proprietary ActRIIA-Fc fusion protein developed by its subsidiary, Immuncare Biopharmaceutical Technology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4168","01541","IMC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735417","title":"ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735417","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735417?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:37","pubTimestamp":1787654273,"startTime":"0","endTime":"0","summary":"ImmuneOnco says first PAH patient dosed in Phase Ib/IIa trial of IMC-003ImmuneOnco Biopharmaceuticals (Shanghai) dosed the first patient in a Phase Ib/IIa pulmonary arterial hypertension trial of IMC-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL71fHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119750546","title":"ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1119750546","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119750546?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:45","pubTimestamp":1787316325,"startTime":"0","endTime":"0","summary":"Hong Kong-listed ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) reported that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260429","title":"ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260429?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:07","pubTimestamp":1787314025,"startTime":"0","endTime":"0","summary":"ImmuneOnco wins FDA IND clearance for IMM0306 lupus Phase Ib/II trialFDA cleared an IND for ImmuneOnco’s IMM0306, enabling a Phase Ib/II trial in systemic lupus erythematosus.IMM0306 is a CD47/CD20 bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL5c90g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260410","title":"ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260410?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:06","pubTimestamp":1787313984,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194284340","title":"ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation","url":"https://stock-news.laohu8.com/highlight/detail?id=1194284340","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194284340?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:49","pubTimestamp":1786697340,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. announced that its board of directors will meet on 26 August 2026. The agenda includes: • Reviewing and approving the interim financial results for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114647","title":"ImmuneOnco Biopharmaceuticals Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114647?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:41","pubTimestamp":1786696903,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals schedules board meeting to review interim resultsImmuneOnco Biopharmaceuticals will hold a board meeting on Aug. 26, 2026 to review interim results for the six months end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL9sJ112:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143946715","title":"Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1143946715","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143946715?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:14","pubTimestamp":1786421692,"startTime":"0","endTime":"0","summary":"The benchmark Hang Seng Index fell 0.63%, dropping 163 points to 25,773 points, while the Hang Seng Tech Index declined 1.27%. Early session turnover on the Hong Kong exchange reached 115.8 billion...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348816934.USD","601899","02099","03037","BK1198","LU0266512473.USD","LU2008162690.USD","82800","LU1770034418.SGD","LU0228659784.USD","LU0049853897.USD","HSTECH","LU0348825331.USD","LU1048596156.SGD","02899","BK1587","LU1188198961.HKD","BK1190","02833","LU2097828557.USD","07300","LU0164880469.USD","LU1105468828.SGD","03423","LU1481107354.HKD","LU2460026573.USD","BK1574","HK0000306685.HKD","LU2264538146.SGD","HSImain","LU0211977185.USD","LU0540923850.HKD","LU0828237510.HKD","01541","LU0287142896.SGD","02631","03115","LU0307460666.USD","BK1169","LU2488822045.USD","LU0979878070.USD","688234","688062","83115","ZLAB","LU0164939612.USD","09088","09067","LU0918141887.USD","LU1794554557.SGD","SG9999002463.SGD","BK1592","LU0370786039.SGD","LU0620787316.HKD","JINFF","HK0000320223.HKD","LU1251922891.USD","LU0244354667.USD","02837","BK1588","LU1242518857.USD","LU2097828631.EUR","06821","LU0278937759.USD","BK1544","LU0561508036.HKD","LU0082770016.USD","LU1808992512.USD","LU1769817096.USD","513600","LU0531971595.HKD","LU2097828474.EUR","LU1282648689.USD","BK1183","LU0106959298.USD","LU0327786744.USD","LU0463099449.HKD","LU0821914370.USD","BK1161","LU0274383008.USD","LU0797268264.HKD","LU0348767384.USD","LU0886674414.USD","LU0082770016.SGD","LU0348827113.USD","HSI","LU1988902786.USD","03033","03032","BK1505","LU0348814723.USD","09115","LU0164865239.USD","06616","LU2399975544.HKD","LU1242518931.SGD","LU0828238088.HKD","07500","01651","LU0269904917.USD","LU0329678170.USD","03067","LU0828237940.HKD","LU0868486357.SGD","07552","LU0173614495.USD","LU0329678337.USD","PONY","MCHmain","03419","BK1129","LU3063872942.SGD","02026","LU1504937902.USD","LU0634319403.HKD","LU0737861699.HKD","LU0348735423.USD","LU0106252389.USD","01548","LU1303224171.USD","07200","LU1224709979.USD","BK1594","LU0918141705.HKD","LU1831875114.USD","09688","LU0345780521.USD","HK0000320264.USD","LU0588546209.SGD","002821","HHImain","LU0456854461.SGD","BK1191","02493","LU0181495838.USD","LU0737861772.HKD","LU0096374516.USD","03088","300408","LU0266512127.USD","LU0061477393.USD","LU0149721374.USD","07226","LU0048580855.USD","HTImain","IE0032431581.USD","LU0345780281.USD","LU1961090484.USD","SG9999004220.SGD","LU0417516902.SGD","LU0348766576.USD","LU0140636845.USD","03417","LU0417516738.SGD","BK1109","LU2177674079.SGD","ZIJMY","HK0000306701.USD","LU2097828805.USD","LU0165289439.USD","BK1170","LU0572944931.SGD","03759","LU2226246903.HKD","LU1064131342.USD","LU0039217434.USD","LU0043850808.USD","LU1720050803.USD","300759","LU0328353924.USD","LU2097828714.EUR","02800","06951","LU0509642566.USD","LU1719994722.HKD","BK1583","SG9999001093.SGD","BK1576","LU0431992006.USD","LU0326950275.SGD","BK1141","LU1769817179.HKD","SG9999003461.SGD","LU0871576103.HKD","LU2039709279.SGD","LU0469268626.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177678527","title":"Hong Kong Stock Movers: IMMUNEONCO-B (01541) Surges Over 14% as Subsidiary Secures First External Commercial Capital to Accelerate Non-Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1177678527","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177678527?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:58","pubTimestamp":1786417095,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) shares surged over 14% in early trading, and as of the time of writing, were up 10.78% to HK$3.495, with a turnover of HK$3.1368 million.On the news front, IMMUNEONCO-B announced...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","01541","KCAI","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144771177","title":"IMMUNEONCO-B shares surge nearly 10% in afternoon trading after subsidiary raises 50 million yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1144771177","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144771177?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:48","pubTimestamp":1786081695,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) shares jumped nearly 10% in the afternoon session, last trading up 8.42% at HK$3.155, with turnover reaching HK$1.5661 million.The rally follows the company's announcement that...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","KCAI","BK1161","BK4585","VXUS","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158359504","title":"IMMUNEONCO-B's Unit Receives 50 Million Yuan Capital Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1158359504","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158359504?lang=en_us&edition=fundamental","pubTime":"2026-08-07 07:02","pubTimestamp":1786057338,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that on August 6, 2026, the company, along with its non-wholly owned subsidiary ImmuneCare BiomedTech (Shanghai) Co., Ltd. (the target company), entered into a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","XBI","161726","399441","BK4581","BK4585","01541","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657669010","title":"ImmuneOnco Affiliate ImmuneCare Attracts RMB 50 Million in Capital Increase for 15.83% Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2657669010","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657669010?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:35","pubTimestamp":1786055710,"startTime":"0","endTime":"0","summary":"ImmuneOnco affiliate ImmuneCare attracts RMB 50 million in capital increase for 15.83% stakeImmuneOnco agreed a RMB 50 million capital increase in non-wholly owned unit ImmuneCare Biopharmaceutical  on Aug. 6, 2026.External investors will subscribe for RMB 465,000 of enlarged registered capital, taking a combined 15.83% stake.ImmuneOnco will convert a RMB 15.86 million shareholder loan into RMB 147,498 of enlarged registered capital at the same price.Post-transaction ownership: ImmuneOnco 68.34%; employee platform Jiaxing Changxin 15.83%; investors 15.83%.ImmuneCare develops drugs for metabolic and rare diseases; proceeds aimed at strengthening funding for ongoing R&D.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneonco Biopharmac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4lt333:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114113376","title":"ImmuneOnco injects RMB50.00 million into ImmuneCare; retains 68.34% stake after capital boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1114113376","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114113376?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:26","pubTimestamp":1786055193,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (ImmuneOnco) has signed a Capital Increase Agreement dated 6 August 2026 to strengthen ImmuneCare Biopharmaceutical (Shanghai) Co., Ltd., its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107619941","title":"ImmuneOnco trims outstanding H-shares by 0.58 million in July; treasury stock rises to 2.02 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1107619941","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107619941?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:47","pubTimestamp":1786006021,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. released its Monthly Return for Equity Issuer, detailing share-capital movements for the month ended 31 July 2026. Share capital   • Registered share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123654394","title":"IMMUNEONCO-B Implements ESOP-Driven Capital Injection into Non-Oncology Subsidiary, Adjusts Shareholding Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=1123654394","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123654394?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:27","pubTimestamp":1785500826,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (“ImmuneOnco”) has issued a supplemental announcement detailing a deemed disposal arising from a capital increase at its non-oncology subsidiary (the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655666903","title":"ImmuneOnco Clarifies Subsidiary Capital Increase as Employee Incentive Scheme Via ESOP Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2655666903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655666903?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:18","pubTimestamp":1785500338,"startTime":"0","endTime":"0","summary":"ImmuneOnco clarifies subsidiary capital increase as employee incentive scheme via ESOP platformImmuneOnco issued a supplemental clarification on its June 18, 2026 deemed disposal tied to a subsidiary capital increase.The unit was set up to raise external private funding for non-oncology R&D, aiming to diversify beyond the group’s core oncology programs.The capital increase was framed as an employee incentive via an ESOP platform, with participants expected to include senior management and core technical staff.It defended par-value subscriptions as standard for ESOPs, citing the target’s net liabilities as of Dec. 31, 2025.The ESOP platform’s control structure was updated: Jiaxing Hanlan holds about 69.92%, Dr. Tian 21.48%, Dr. Zheng 8.6%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL159cYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156641678","title":"ImmuneOnco Completes HKD 0.19 Million H-Share Buyback, Issued Share Count Trimmed to 418.46 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1156641678","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156641678?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:24","pubTimestamp":1784892267,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B) disclosed that it repurchased 58,200 H-shares on 24 July 2026 through on-market transactions on the Hong Kong Stock Exchange at prices...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":109,"code":"91000000","status":"200"}]}}